Open to Laparoscopic Reverse Conversion of Perforated Appendicitis
reverse
A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in Management of Acute Perforated Appendicitis
1 other identifier
interventional
426
1 country
1
Brief Summary
A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in management of Acute Perforated Appendicitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2021
CompletedFirst Submitted
Initial submission to the registry
February 18, 2022
CompletedFirst Posted
Study publicly available on registry
March 17, 2022
CompletedMarch 17, 2022
March 1, 2022
3.9 years
February 18, 2022
March 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
the rates of intraabdominal abscess
rates of complications
3 months post operative
rates of wound infection
rates of complications
3 months post operative
rates of ileus
Baseline (Hospital admission)
rates of reoperation
3 months post operative
Secondary Outcomes (2)
The hospital length of stay
up to 3 months
the operative time
Intraoperative
Study Arms (2)
group A
EXPERIMENTALthe group who was subjected to the reverse conversion technique
group B
NO INTERVENTIONthe control group who was completed by open technique
Interventions
converting open appendectomy to laparoscopic technique for proper control of intraabdominal sepsis
Eligibility Criteria
You may qualify if:
- symptoms consistent with acute perforated appendicitis,
- had ultrasound or computed tomography (CT) evidence of acute perforated appendicitis,
- ages ranging from 16 to 65 years.
You may not qualify if:
- radiological evidence of appendicular mass,
- septic shock or multi-organ failure (MOF) at presentation,
- Diabetes Mellitus (DM), renal failure, morbid obesity
- recent (6-month) history of thromboembolic disease
- immunomodulators,
- a history of inflammatory bowel disease (IBD),
- postoperative pathological report of the removed appendix revealed carcinoid or Crohn's disease,
- American Society of Anesthesiology (ASA) classification more than II.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University
Zagazig, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
February 18, 2022
First Posted
March 17, 2022
Study Start
January 18, 2018
Primary Completion
December 15, 2021
Study Completion
December 25, 2021
Last Updated
March 17, 2022
Record last verified: 2022-03